New drug approval process: global challenges and solutions
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York
Informa Healthcare USA
2009
|
| Ausgabe: | 5. ed. |
| Schriftenreihe: | Drugs and the pharmaceutical sciences
190 |
| Schlagworte: | |
| Beschreibung: | Includes bibliographical references and index |
| Beschreibung: | XVIII, 529 S. cm |
| ISBN: | 9781420088496 1420088491 |
Internformat
MARC
| LEADER | 00000nam a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV035668928 | ||
| 003 | DE-604 | ||
| 005 | 20091019 | ||
| 007 | t | ||
| 008 | 090809s2009 xxu |||| 00||| eng d | ||
| 010 | |a 2009007532 | ||
| 020 | |a 9781420088496 |c hardcover : alk. paper |9 978-1-420-08849-6 | ||
| 020 | |a 1420088491 |c hardcover : alk. paper |9 1-420-08849-1 | ||
| 035 | |a (OCoLC)643003594 | ||
| 035 | |a (DE-599)BVBBV035668928 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c US | ||
| 049 | |a DE-12 | ||
| 050 | 0 | |a RS189 | |
| 082 | 0 | |a 615/.1 | |
| 245 | 1 | 0 | |a New drug approval process |b global challenges and solutions |c ed. by Richard Guarino |
| 250 | |a 5. ed. | ||
| 264 | 1 | |a New York |b Informa Healthcare USA |c 2009 | |
| 300 | |a XVIII, 529 S. |c cm | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Drugs and the pharmaceutical sciences |v 190 | |
| 500 | |a Includes bibliographical references and index | ||
| 650 | 4 | |a Clinical Trials as Topic - standards - United States | |
| 650 | 4 | |a Drug Approval - United States | |
| 650 | 4 | |a Drug Evaluation - standards - United States | |
| 650 | 4 | |a Drug approval - United States | |
| 650 | 4 | |a Drugs - Testing | |
| 650 | 4 | |a Gevernment policy - United States | |
| 650 | 4 | |a New products - Government policy - United States | |
| 650 | 4 | |a Standards | |
| 650 | 4 | |a Politik | |
| 650 | 4 | |a Drug approval |z United States | |
| 650 | 4 | |a Drugs |x Testing |x Standards | |
| 650 | 4 | |a Drugs |x Testing |x Gevernment policy |z United States | |
| 650 | 4 | |a New products |x Government policy |z United States | |
| 650 | 4 | |a Drug Evaluation |x standards |z United States | |
| 650 | 4 | |a Clinical Trials as Topic |x standards |z United States | |
| 650 | 4 | |a Drug Approval |z United States | |
| 650 | 0 | 7 | |a Richtlinie |0 (DE-588)4137814-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelprüfung |0 (DE-588)4128030-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Zulassung |0 (DE-588)4127410-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
| 651 | 4 | |a USA | |
| 651 | 7 | |a USA |0 (DE-588)4078704-7 |2 gnd |9 rswk-swf | |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
| 689 | 0 | 1 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
| 689 | 0 | 2 | |a Zulassung |0 (DE-588)4127410-6 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
| 689 | 1 | 1 | |a Arzneimittelprüfung |0 (DE-588)4128030-1 |D s |
| 689 | 1 | 2 | |a Richtlinie |0 (DE-588)4137814-3 |D s |
| 689 | 1 | |8 1\p |5 DE-604 | |
| 700 | 1 | |a Guarino, Richard A. |d 1935- |e Sonstige |0 (DE-588)139424458 |4 oth | |
| 830 | 0 | |a Drugs and the pharmaceutical sciences |v 190 |w (DE-604)BV000002008 |9 190 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-017723227 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
Datensatz im Suchindex
| _version_ | 1804139363479584768 |
|---|---|
| any_adam_object | |
| author_GND | (DE-588)139424458 |
| building | Verbundindex |
| bvnumber | BV035668928 |
| callnumber-first | R - Medicine |
| callnumber-label | RS189 |
| callnumber-raw | RS189 |
| callnumber-search | RS189 |
| callnumber-sort | RS 3189 |
| callnumber-subject | RS - Pharmacy |
| ctrlnum | (OCoLC)643003594 (DE-599)BVBBV035668928 |
| dewey-full | 615/.1 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.1 |
| dewey-search | 615/.1 |
| dewey-sort | 3615 11 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| edition | 5. ed. |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02810nam a2200745zcb4500</leader><controlfield tag="001">BV035668928</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20091019 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">090809s2009 xxu |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2009007532</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781420088496</subfield><subfield code="c">hardcover : alk. paper</subfield><subfield code="9">978-1-420-08849-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1420088491</subfield><subfield code="c">hardcover : alk. paper</subfield><subfield code="9">1-420-08849-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)643003594</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV035668928</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RS189</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.1</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">New drug approval process</subfield><subfield code="b">global challenges and solutions</subfield><subfield code="c">ed. by Richard Guarino</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">5. ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Informa Healthcare USA</subfield><subfield code="c">2009</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XVIII, 529 S.</subfield><subfield code="c">cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Drugs and the pharmaceutical sciences</subfield><subfield code="v">190</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Trials as Topic - standards - United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Approval - United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Evaluation - standards - United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug approval - United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs - Testing</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gevernment policy - United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">New products - Government policy - United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Standards</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Politik</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug approval</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Testing</subfield><subfield code="x">Standards</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Testing</subfield><subfield code="x">Gevernment policy</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">New products</subfield><subfield code="x">Government policy</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Evaluation</subfield><subfield code="x">standards</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Trials as Topic</subfield><subfield code="x">standards</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Approval</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Richtlinie</subfield><subfield code="0">(DE-588)4137814-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelprüfung</subfield><subfield code="0">(DE-588)4128030-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Zulassung</subfield><subfield code="0">(DE-588)4127410-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Zulassung</subfield><subfield code="0">(DE-588)4127410-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Arzneimittelprüfung</subfield><subfield code="0">(DE-588)4128030-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Richtlinie</subfield><subfield code="0">(DE-588)4137814-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Guarino, Richard A.</subfield><subfield code="d">1935-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)139424458</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Drugs and the pharmaceutical sciences</subfield><subfield code="v">190</subfield><subfield code="w">(DE-604)BV000002008</subfield><subfield code="9">190</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-017723227</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| geographic | USA USA (DE-588)4078704-7 gnd |
| geographic_facet | USA |
| id | DE-604.BV035668928 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T21:42:54Z |
| institution | BVB |
| isbn | 9781420088496 1420088491 |
| language | English |
| lccn | 2009007532 |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-017723227 |
| oclc_num | 643003594 |
| open_access_boolean | |
| owner | DE-12 |
| owner_facet | DE-12 |
| physical | XVIII, 529 S. cm |
| publishDate | 2009 |
| publishDateSearch | 2009 |
| publishDateSort | 2009 |
| publisher | Informa Healthcare USA |
| record_format | marc |
| series | Drugs and the pharmaceutical sciences |
| series2 | Drugs and the pharmaceutical sciences |
| spelling | New drug approval process global challenges and solutions ed. by Richard Guarino 5. ed. New York Informa Healthcare USA 2009 XVIII, 529 S. cm txt rdacontent n rdamedia nc rdacarrier Drugs and the pharmaceutical sciences 190 Includes bibliographical references and index Clinical Trials as Topic - standards - United States Drug Approval - United States Drug Evaluation - standards - United States Drug approval - United States Drugs - Testing Gevernment policy - United States New products - Government policy - United States Standards Politik Drug approval United States Drugs Testing Standards Drugs Testing Gevernment policy United States New products Government policy United States Drug Evaluation standards United States Clinical Trials as Topic standards United States Drug Approval United States Richtlinie (DE-588)4137814-3 gnd rswk-swf Arzneimittelprüfung (DE-588)4128030-1 gnd rswk-swf Zulassung (DE-588)4127410-6 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf USA USA (DE-588)4078704-7 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content USA (DE-588)4078704-7 g Arzneimittel (DE-588)4003115-9 s Zulassung (DE-588)4127410-6 s DE-604 Arzneimittelprüfung (DE-588)4128030-1 s Richtlinie (DE-588)4137814-3 s 1\p DE-604 Guarino, Richard A. 1935- Sonstige (DE-588)139424458 oth Drugs and the pharmaceutical sciences 190 (DE-604)BV000002008 190 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | New drug approval process global challenges and solutions Drugs and the pharmaceutical sciences Clinical Trials as Topic - standards - United States Drug Approval - United States Drug Evaluation - standards - United States Drug approval - United States Drugs - Testing Gevernment policy - United States New products - Government policy - United States Standards Politik Drug approval United States Drugs Testing Standards Drugs Testing Gevernment policy United States New products Government policy United States Drug Evaluation standards United States Clinical Trials as Topic standards United States Drug Approval United States Richtlinie (DE-588)4137814-3 gnd Arzneimittelprüfung (DE-588)4128030-1 gnd Zulassung (DE-588)4127410-6 gnd Arzneimittel (DE-588)4003115-9 gnd |
| subject_GND | (DE-588)4137814-3 (DE-588)4128030-1 (DE-588)4127410-6 (DE-588)4003115-9 (DE-588)4078704-7 (DE-588)4143413-4 |
| title | New drug approval process global challenges and solutions |
| title_auth | New drug approval process global challenges and solutions |
| title_exact_search | New drug approval process global challenges and solutions |
| title_full | New drug approval process global challenges and solutions ed. by Richard Guarino |
| title_fullStr | New drug approval process global challenges and solutions ed. by Richard Guarino |
| title_full_unstemmed | New drug approval process global challenges and solutions ed. by Richard Guarino |
| title_short | New drug approval process |
| title_sort | new drug approval process global challenges and solutions |
| title_sub | global challenges and solutions |
| topic | Clinical Trials as Topic - standards - United States Drug Approval - United States Drug Evaluation - standards - United States Drug approval - United States Drugs - Testing Gevernment policy - United States New products - Government policy - United States Standards Politik Drug approval United States Drugs Testing Standards Drugs Testing Gevernment policy United States New products Government policy United States Drug Evaluation standards United States Clinical Trials as Topic standards United States Drug Approval United States Richtlinie (DE-588)4137814-3 gnd Arzneimittelprüfung (DE-588)4128030-1 gnd Zulassung (DE-588)4127410-6 gnd Arzneimittel (DE-588)4003115-9 gnd |
| topic_facet | Clinical Trials as Topic - standards - United States Drug Approval - United States Drug Evaluation - standards - United States Drug approval - United States Drugs - Testing Gevernment policy - United States New products - Government policy - United States Standards Politik Drug approval United States Drugs Testing Standards Drugs Testing Gevernment policy United States New products Government policy United States Drug Evaluation standards United States Clinical Trials as Topic standards United States Drug Approval United States Richtlinie Arzneimittelprüfung Zulassung Arzneimittel USA Aufsatzsammlung |
| volume_link | (DE-604)BV000002008 |
| work_keys_str_mv | AT guarinoricharda newdrugapprovalprocessglobalchallengesandsolutions |